Search alternatives:
mg decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
12 mean » 12 men (Expand Search), 2012 mean (Expand Search)
50 mg » 10 mg (Expand Search)
mg decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
_ decrease » _ decreased (Expand Search)
12 mean » 12 men (Expand Search), 2012 mean (Expand Search)
50 mg » 10 mg (Expand Search)
-
1
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50.
Published 2024“…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
-
10
Ageing results in an abrupt decrease in overall neurogenesis in the mouse DG.
Published 2013“…<p>C57BL/6J male mice with 1.5, 3, 6, 9, and 12 months of age received BrdU injections (200 mg/kg i.p.) every 12 hours for 3 consecutive days and were sacrificed by transcardial perfusion 42 days later, to allow enough time for differentiation of the proliferating cells that incorporated BrdU. …”
-
11
-
12
-
13
-
14
-
15
Mean percentage changes (95% CI) in total testosterone, SHBG and free testosterone (mITT analysis).
Published 2024Subjects: -
16
-
17
-
18
-
19
PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis
Published 2016“…<b><i>Results:</i></b> Mean ± SE serum K decreased (maximum change per corresponding day, 0.6 ± 0.2 mEq/l, p = 0.009) and fecal K increased 58% on patiromer compared with the pretreatment week. …”
-
20